- In March 2024, Drägerwerk AG & Co. KGaA, a global leader in medical and safety technology, introduced the Evita V600 and V800 ventilators equipped with enhanced intelligent ventilation modes and user-friendly interfaces. These advanced systems support individualized respiratory care, particularly in intensive care units (ICUs), enhancing both clinical workflow and patient outcomes. The launch underscores Dräger's commitment to delivering precision-driven and patient-adaptive ventilation solutions tailored to diverse critical care settings
- In February 2024, Medtronic plc, a key player in respiratory care, launched its portable Puritan Bennett 560+ ventilator aimed at addressing growing demand for reliable home ventilation solutions. This next-generation device offers compact design, long battery life, and advanced alarm features, making it ideal for home-bound patients with chronic respiratory conditions. The launch reflects Medtronic’s strategy to improve accessibility and convenience in long-term respiratory support
- In February 2024, Getinge AB announced a strategic partnership with several European hospitals for clinical trials of its Servo-u ventilator integrated with artificial intelligence to automatically adjust ventilation parameters based on real-time patient data. The collaboration is focused on improving patient outcomes through automation, reducing complications such as ventilator-induced lung injury. This initiative highlights Getinge’s innovation-led approach in intensive care technology
- In January 2024, Hamilton Medical AG introduced upgrades to its HAMILTON-C6 ventilator, integrating enhanced lung protection features and improved graphical interfaces for better patient-ventilator interaction. Designed for high-acuity patients, the device supports advanced modes such as INTELLiVENT-ASV, which automates ventilation based on continuous monitoring of CO₂ and SpO₂. The enhancement supports clinicians in delivering safe, personalized respiratory therapy
- In December 2023, Philips Respironics received FDA clearance for its new-generation Trilogy Evo OBM (hospital-to-home ventilator), designed for pediatric and adult patients requiring long-term respiratory support. This model includes cloud-based data sharing and customizable alarms, ensuring seamless transitions across care settings. The development reflects Philips’ ongoing commitment to bridging gaps in chronic care and enhancing patient mobility through connected health technologies
